Amplified Sciences has developed a proprietary ultra-sensitive universal optical reporter platform technology which enables a new class of multi-omics diagnostic tests including a novel protease turnover multianalyte assay.
PanCystPro uses a proprietary platform to detect biomarker levels and activity in minute volumes of pancreatic cyst fluid for patients at higher risk for pancreatic cancer diagnosed with pancreatic cystic lesions.
Amplified Sciences is a clinical stage diagnostics company committed to providing answers for clinicians diagnosing, treating and monitoring challenging diseases. The company is built on an innovative and proprietary ultra-sensitive optical reporter platform technology. Our team of scientists and commercial experts is focused on providing tools for accurate, earlier detection of debilitating diseases.
